Sanara MedTech Inc
|Market Cap (Intraday)||200.10M|
|2yr Forward PE||N/A|
Sanara MedTech Inc Stock, NASDAQ:SMTI
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.